Perrigo’s acquisition of Paddock Labs put on hold
ALLEGAN, Mich. — Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.
"We are looking forward to concluding the transaction as soon as possible,” Perrigo chairman and CEO Joseph Papa said. “We have recently received a few additional questions from the Federal Trade Commission staff, and the parties are working collaboratively with the staff to answer these questions so that the FTC may conclude its review,” he said.
The acquisition is an important step toward expanding Perrigo’s specialty portfolio of generic pharmaceutical products, Papa said.
Smarticle Industries brings StingOut to market
HONOLULU — Smarticle Industries on Wednesday announced the launch of StingOut, a product designed to soothe the sting of the box jellyfish and the Portuguese man-of-war, which has been found in waters from Texas and Florida to the northeastern United States.
Retailing for a suggested $12.95, each StingOut kit includes a packet of a sting relief gel and plastic gloves. What’s unique about the StingOut kit is that the packet itself is designed to be used as a scraper to help remove the irritating tentacles of box jellyfish. The gloves are important because when treating a jellyfish sting, no one should come into contact with the sting-producing jellyfish tentacles. Rubbing the affected area also is not advised, as it can help spread the toxins produced by the tentacles.
Jellyfish venom can continue to cause pain and discomfort for up to 10 days, and StingOut can be used on a daily basis as needed for follow-up.
"Anyone who has ever been stung by a jellyfish knows how excruciatingly painful it is," Smarticle spokeswoman Kerry Holyoak said. "A jellyfish sting can ruin an entire day — or even an entire vacation. We’ve developed StingOut to help people enjoy their time at the beach."
Rash of Tylenol recalls not over
FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Tuesday initiated another recall at the retail level of one product lot (60,912 bottles) of Tylenol extra strength caplets in 225-count bottles because of a small number of odor reports, including a musty, moldy odor.
The uncharacteristic musty, moldy odor has been linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA).
The product lot number (ABA619) for the recalled product can be found on the side of the bottle label. The recalled product was manufactured in February 2009.
This recall is being conducted with the knowledge of the Food and Drug Administration, McNeil stated.